Northeast Financial Consultants Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Northeast Financial Consultants Inc

  • $2.25 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$7.6 - $11.41 $76,988 - $115,583
-10,130 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$9.3 - $12.37 $12,183 - $16,204
-1,310 Reduced 11.45%
10,130 $101,000
Q3 2021

Nov 15, 2021
BUY
$11.39 - $16.23 $130,301 - $185,671
11,440 New
11,440 $130,000
Q3 2020

Oct 29, 2020
SELL
$15.21 - $25.53 $126,090 - $211,643
-8,290 Closed
0 $0
Q2 2020

Jul 30, 2020
BUY
$15.08 - $26.0 $125,013 - $215,540
8,290 New
8,290 $210,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $676M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email